Your leading voice in digital health news
Twitter X Logo

NICE recommends ‘evidence generation period’ for AI imaging

5 November 2026
By Dawn O'Shea
The UK’s National Institute for Health and Care Excellence (NICE) has published draft guidance which names five prostate cancer AI imaging tools that can be used within the NHS over a two-year “evidence generation period”. The five named technologies are Siemen’s AI‑Rad Companion Prostate MR, DeepHealth Prostate, ProstatID (Bot Image), Lucida Medical’s Prostate Intelligence (Pi), […]

Subscribe to read more

Pulse+IT website access

Keep your finger on the pulse with full access to all articles published on pulseit.news
Instant access
All articles
Cancel anytime

Your leading voice in digital health news

Twitter X

Your leading voice in digital health news 

Keep your finger on the pulse with full access to all articles published on 
pulseit.news
Subscribe from only $39
magnifiercrossmenuchevron-down